Antimicrobial action plan
This article was originally published in The Rose Sheet
Executive Summary
Evaluation of benefits/risks of incorporating antimicrobial disinfectants or chemicals into consumer products such as soap included in final interdepartmental antimicrobial resistance action plan unveiled by HHS Jan. 18. Although not specified in the final version, a draft released in June said agencies likely will consider whether such products "have any efficacy in reducing infection" and if they "play a role in promoting drug resistance" (1"The Rose Sheet" June 26, 2000, p. 8). Developed by the Task Force on Antimicrobial Resistance, the plan designates priorities, identifies responsible agencies and creates timelines for facilitating surveillance, prevention and control, research and product development to address antimicrobial resistance. CDC, NIH and FDA are leading task force of 10 agencies and departments
You may also be interested in...
Antimicrobial resistance report
Antimicrobial Resistance Interagency Task Force presents second 1annual progress report on a public health action plan to combat antimicrobial resistance during a meeting June 25 in Bethesda, Md. Second annual report focuses on domestic issues, such as implementing a national antimicrobial resistance surveillance plan. Interagency task force includes Centers for Disease Control and Prevention, FDA and National Institutes of Health. Evaluation of benefits and risks in consumer products such as soap were included in action plan unveiled by HHS in 2001 (2"The Rose Sheet" Jan. 22, 2001, In Brief)...
Antimicrobial resistance report
Antimicrobial Resistance Interagency Task Force presents second 1annual progress report on a public health action plan to combat antimicrobial resistance during a meeting June 25 in Bethesda, Md. Second annual report focuses on domestic issues, such as implementing a national antimicrobial resistance surveillance plan. Interagency task force includes Centers for Disease Control and Prevention, FDA and National Institutes of Health. Evaluation of benefits and risks in consumer products such as soap were included in action plan unveiled by HHS in 2001 (2"The Rose Sheet" Jan. 22, 2001, In Brief)...
Antimicrobial resistance
FDA, CDC and NIH will host public meeting Sept. 26 in San Diego, Calif. to solicit comments on development of Public Health Action Plan to Combat Antimicrobial Resistance. Discussion will center on second part of the action plan (global issues). Agencies held a meeting in June to discuss surveillance, prevention and control, research and product development. Evaluation of benefits and risks of antimicrobials in consumer products such as soap were included in action plan unveiled by HHS in 2001 (1"The Rose Sheet" Jan. 22, 2001, In Brief)...